Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

SHILPA MEDICARE LTD. - 530549 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015

 SHILPA MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2021 ,inter alia, to consider and approve With reference to the subject cited above, we wish to inform you that a meeting of the Board of Directors of Shilpa Medicare Limited will be held on Saturday, the 13th Day of February, 2021, to inter alia transact the following items of business: Approval of the Un Audited Standalone and Consolidated Financial Results of the Company for Third Quarter ended 31st December, 2020 . This is for your information and records.
05-02-2021
Bigul

SHILPA MEDICARE LTD. - 530549 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

 With reference to the above captioned subject, Please be noted that Mr. Sushil Bajaj, Chief Financial Officer of Shilpa Medicare Limited has tendered his resignation letter. The same has been accepted by the Board of Directors through Circular Resolution and he will be relieved w.e.f. 20th January, 2021.
19-01-2021
Bigul

SHILPA MEDICARE LTD. - 530549 - Shareholding for the Period Ended December 31, 2020

 Shilpa Medicare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here
15-01-2021
Bigul

SHILPA MEDICARE LTD. - 530549 - Statement Of Investor Complaints For The Quarter Ended December 2020

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0770 Name of the Signatory :- V V KRISHNA CHAITANYADesignation :- Company Secretary and Compliance Officer
11-01-2021
Bigul

SHILPA MEDICARE LTD. - 530549 - Closure of Trading Window

 With reference to the above subject it is hereby informed that the trading window of Shilpa Medicare Limited will remain closed for dealing in the securities of the Company for all Designated Employees/ Persons and their immediate relatives with effect from 01st January, 2021 till the end of 48 hours from the declaration of the financial results for the Third Quarter ended 31st December, 2020
30-12-2020
Bigul

SHILPA MEDICARE LTD. - 530549 - Announcement under Regulation 30 (LODR)-Credit Rating

 We hereby inform you that India Ratings and Research Private Limited (A Fitch Group Company) has assigned a long term rating of IND A+/Stable and short term rating of IND A+/Stable/IND A1 against the existing ratings of long term rating of ICRA A (Stable) and short term rating of ICRA A1 assigned by ICRA.
15-12-2020
Bigul

SHILPA MEDICARE LTD. - 530549 - Sub: Submission Of Related Party Transactions U/R 23(9) Of SEBI (Listing Obligations Disclosure Requirements) Regulations, 2015 For The Half Year Ended 30Th September, 2020. Ref. - SCRIP CODE & ID: 530549, SHILPAMED

 Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find herewith enclosed Related Party Transactions on consolidated basis in the format as per the relevant Accounting Standards for the Half Year ended 30th September, 2020
11-11-2020
Bigul

SHILPA MEDICARE LTD. - 530549 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vishnukant C Bhutada
11-11-2020
Bigul

SHILPA MEDICARE LTD. - 530549 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kamal Kishore Innani & PACs
09-11-2020
Bigul

SHILPA MEDICARE LTD. - 530549 - Announcement under Regulation 30 (LODR)-Investor Presentation

 Pursuant to the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended from time to time, please find herewith enclosed copy of 02nd Quarter of Financial Year 2020-21 Results presentation made to analysts and Investors. This is for your information and Records.
02-11-2020
Next Page
Close

Let's Open Free Demat Account